Sandoz News

  • 17-07-2008 Latest Results - Q2 2008

    Novartis gains momentum with strong performance in first half of ...

  • 13-05-2008 International presentation of clinical safety and efficacy data for Binocrit®, the world’s first complex biosimilar

    • - First international presentation of clinical evidence supporting a biopharmaceutical approved by the biosimilar regulatory process
    • - Data demonstrate safety and efficacy of Binocrit® in anemia treatment
    • - Sandoz further confirms pioneering position in biosimilars, enhancing patient access to high-quality, affordable biopharmaceuticals

Sandoz Websites

Welcome to Sandoz

You have just entered the world of Sandoz - a healthy decision. Sandoz is a global leader in the rapidly growing generics industry, present in more than 130 countries. If you are interested in Sandoz International, you are already at the right place. To find out more about a specific country, just click on the worldwide map.
If you have any further questions, please contact us.

Corporate Image Video

Do you want to explore the world of Sandoz? Watch our corporate movie here.

Pioneering biosimilars:

Pioneering biosimilars:

Sandoz is at the forefront of bringing biosimilars to patients worldwide

Sandoz International TB Symposium

Sandoz International TB Symposium

Find out more about what we are doing to stop tuberculosis

Sandoz Theme map

Sandoz Theme map

See what are the current hot topics at Sandoz

Sandoz History

Sandoz History

A virtual journey into the historical roots of our company.